Clinical Trials Directory

Trials / Completed

CompletedNCT05532592

Investigation on the Hesitancy of COVID-19 Vaccination Among Liver Transplant Recipients in China

Status
Completed
Phase
Study type
Observational
Enrollment
449 (actual)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.

Detailed description

On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Questionnaire items including demographic characteristics, understanding of COVID-19, attitude toward COVID-19 vaccine. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.

Conditions

Interventions

TypeNameDescription
OTHERPerceptions and attitudes towards COVID-19 and COVID-19 vaccineAttitude towards COVID-19; Knowledge about COVID-19 vaccine

Timeline

Start date
2022-04-27
Primary completion
2022-05-10
Completion
2022-05-30
First posted
2022-09-08
Last updated
2022-09-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05532592. Inclusion in this directory is not an endorsement.